FDA infant formula info
This article was originally published in The Tan Sheet
Executive Summary
Revamped 1CFSAN formula Web site features expanded, easy-to-find "frequently asked questions" section, including Q&As on DHA, ARA. Site, which includes "information about infant formula that may be helpful to industry, consumers, government agencies and other interested parties," launched Jan. 10 in effort to consolidate relevant material. Site now includes guidance documents, advisory committee meeting info and a section on exempt formulas...
You may also be interested in...
US High Court Punts On ‘Objective Falsity’ FCA Standard
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
Warning Letter Close-Outs – February 2021
No device-related close-out letters were released by the US FDA last month.
EU Launches ‘Structured Dialog’ To Thrash Out Supply Chain Concerns
The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: